Yes but EUA will require manufacturing capability ASAP. Only a BP can provide that. If results are good we need to start a Phase 3 and ramp manufacturing yesterday so that we have a real shot at EUA.
Regeneron is making $2.5B/quarter on their antibody treatment. Waiting months and months to get government funding is not a good option. I expect we'll be on the market through EUA with a BP partner long before we see a single dollar of direct government funding.
"in reading the 10-K very closely two things are abundantly clear (among others). 1. Leo is working toward a partnership. (Probably with Gilead) and, 2. Leo is applying for two different forms of EUAs and EUA like fundings."
You mean between the lines, right? Because there are no lines in there that say that stuff other than the multitude of partnership references, which Leo has been working toward for years...per every 10-K. (There were actually 2 LESS "partner" references this year than last year.)
What are the two different forms of EUAs? What's an "EUA like funding"?
News 
Market Data 
Discover 
